Samsung Biologics banks on antibody drugs as fifth factory progresses
With the 1.98 trillion won ($1.47 billion), 180,000-liter (163,000-quart) Plant 5 slated to begin operation in April 2025, Samsung Biologics is set to secure a contract manufacturing capacity of 784,000 liters a year.